Pretreatment HBsAg level and an early decrease in MELD score predict prognosis to lamivudine treatment for HBeAg-negative acute-on-chronic liver failure (Q42234290)

From Wikidata
Jump to navigation Jump to search
scientific article published on 30 December 2013
edit
Language Label Description Also known as
English
Pretreatment HBsAg level and an early decrease in MELD score predict prognosis to lamivudine treatment for HBeAg-negative acute-on-chronic liver failure
scientific article published on 30 December 2013

    Statements

    Pretreatment HBsAg level and an early decrease in MELD score predict prognosis to lamivudine treatment for HBeAg-negative acute-on-chronic liver failure (English)
    30 December 2013
    331-336

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit